DK1866338T3 - Antistoffer mod cd38 til behandling af myelomatose - Google Patents
Antistoffer mod cd38 til behandling af myelomatoseInfo
- Publication number
- DK1866338T3 DK1866338T3 DK06722861.9T DK06722861T DK1866338T3 DK 1866338 T3 DK1866338 T3 DK 1866338T3 DK 06722861 T DK06722861 T DK 06722861T DK 1866338 T3 DK1866338 T3 DK 1866338T3
- Authority
- DK
- Denmark
- Prior art keywords
- myeloma
- treatment
- antibodies against
- antibodies
- Prior art date
Links
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 title 1
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 title 1
- 206010035226 Plasma cell myeloma Diseases 0.000 title 1
- 201000000050 myeloid neoplasm Diseases 0.000 title 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200500429 | 2005-03-23 | ||
| US66757905P | 2005-04-01 | 2005-04-01 | |
| US69616305P | 2005-07-01 | 2005-07-01 | |
| US72856105P | 2005-10-20 | 2005-10-20 | |
| PCT/DK2006/000166 WO2006099875A1 (en) | 2005-03-23 | 2006-03-23 | Antibodies against cd38 for treatment of multiple myeloma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1866338T3 true DK1866338T3 (da) | 2017-01-02 |
Family
ID=50644285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06722861.9T DK1866338T3 (da) | 2005-03-23 | 2006-03-23 | Antistoffer mod cd38 til behandling af myelomatose |
Country Status (12)
| Country | Link |
|---|---|
| KR (1) | KR20140033240A (cs) |
| BE (1) | BE2017C062I2 (cs) |
| DK (1) | DK1866338T3 (cs) |
| ES (2) | ES2644982T3 (cs) |
| HU (2) | HUE034962T2 (cs) |
| LT (2) | LT2567976T (cs) |
| NZ (2) | NZ600059A (cs) |
| PL (1) | PL1866338T3 (cs) |
| PT (2) | PT2567976T (cs) |
| RS (1) | RS55442B1 (cs) |
| SG (1) | SG10201610317VA (cs) |
| UA (2) | UA116520C2 (cs) |
-
2006
- 2006-03-23 ES ES12178778.2T patent/ES2644982T3/es active Active
- 2006-03-23 PT PT121787782T patent/PT2567976T/pt unknown
- 2006-03-23 ES ES06722861.9T patent/ES2606762T3/es active Active
- 2006-03-23 SG SG10201610317VA patent/SG10201610317VA/en unknown
- 2006-03-23 NZ NZ600059A patent/NZ600059A/en not_active Application Discontinuation
- 2006-03-23 DK DK06722861.9T patent/DK1866338T3/da active
- 2006-03-23 UA UAA201204050A patent/UA116520C2/uk unknown
- 2006-03-23 LT LTEP12178778.2T patent/LT2567976T/lt unknown
- 2006-03-23 KR KR1020147004315A patent/KR20140033240A/ko not_active Ceased
- 2006-03-23 PT PT67228619T patent/PT1866338T/pt unknown
- 2006-03-23 PL PL06722861T patent/PL1866338T3/pl unknown
- 2006-03-23 HU HUE12178778A patent/HUE034962T2/en unknown
- 2006-03-23 LT LTEP06722861.9T patent/LT1866338T/lt unknown
- 2006-03-23 RS RS20161147A patent/RS55442B1/sr unknown
- 2006-03-23 UA UAA200711639A patent/UA98756C2/ru unknown
- 2006-03-23 HU HUE06722861A patent/HUE030783T2/en unknown
- 2006-03-23 NZ NZ625944A patent/NZ625944A/en unknown
-
2017
- 2017-11-30 BE BE2017C062C patent/BE2017C062I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140033240A (ko) | 2014-03-17 |
| LT2567976T (lt) | 2017-12-11 |
| PL1866338T3 (pl) | 2017-04-28 |
| PT2567976T (pt) | 2017-10-19 |
| ES2644982T3 (es) | 2017-12-01 |
| ES2606762T3 (es) | 2017-03-27 |
| BE2017C062I2 (cs) | 2025-12-03 |
| HUE030783T2 (en) | 2017-06-28 |
| HUE034962T2 (en) | 2018-03-28 |
| RS55442B1 (sr) | 2017-04-28 |
| UA116520C2 (uk) | 2018-04-10 |
| UA98756C2 (ru) | 2012-06-25 |
| PT1866338T (pt) | 2016-12-14 |
| SG10201610317VA (en) | 2017-02-27 |
| NZ600059A (en) | 2016-01-29 |
| LT1866338T (lt) | 2017-01-25 |
| NZ625944A (en) | 2016-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL284991A (en) | Antibodies against cd38 for treatment of multiple myeloma | |
| DK3421498T3 (da) | Monoklonale antistoffer mod claudin-18 til behandling af cancer | |
| DK3401334T5 (da) | Monoklonale antistoffer mod claudin-18 til cancerbehandling | |
| DK1893586T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-3-phenyluraciler | |
| DK2431359T3 (da) | Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK2178863T3 (da) | Fremgangsmåde til syntetisering af anvendelige forbindelser til behandling af hepatitis C | |
| DK2781593T3 (da) | Fremgangsmåde til behandling af methanemissioner | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
| DK2034830T3 (da) | Anti-vla-1-antistof til behandling af slagtilfælde | |
| DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
| DK3199180T3 (da) | Epha3-antistoffer til behandlingen af faste tumorer | |
| DK3403657T3 (da) | Anvendelse af oligouronater til behandling af slimhyperviskositet | |
| DK1801108T3 (da) | Morpholinforbindelser til behandling af inflammationer. | |
| IL243687A0 (en) | For the treatment of multiple myeloma 1–cs antibodies against | |
| DK3332789T3 (da) | Cladribinkur til behandling af multipel sklerose | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1912961T3 (da) | Fremgangsmåde til fremstilling af bepromolin | |
| DK1866338T3 (da) | Antistoffer mod cd38 til behandling af myelomatose | |
| DK1937662T3 (da) | Fremgangsmåde til fremstilling af duloxetin | |
| DK1727792T3 (da) | Fremgangsmåde til fremstilling af semicarbazoner | |
| DK2121649T3 (da) | Fremgangsmåde til fremstilling af benzofuran-2-carboxamider | |
| DK1833814T3 (da) | Fremgangsmåde til fremstilling af substituerede 2-alkoxycarbonyl-3-aminothiophener |